BioCentury | Nov 23, 1998
Company News

Chrysalis International, Phoenix International Life Sciences Inc. deal

...assume CRLS's $10.5 million debt. CRLS will downsize and consolidate certain clinical operations into PHX. Chrysalis International Corp....
BioCentury | Jul 6, 1998
Company News

Serologicals board of directors update

...Corp. (SERO), Atlanta, Ga. Business: Supply/Service Appointed: Desmond O'Connell, director and executive committee member of Chrysalis International Corp. WIR...
BioCentury | Apr 27, 1998
Company News

Chrysalis International deal

...the partner requested changes in the clinical protocol based on results from other clinical studies. Chrysalis International Corp....
BioCentury | Mar 23, 1998
Company News

Chrysalis International, MDS deal

...between CRLS and MDS’s MDS Pharmaceutical Services Division (Princeton, N.J.), a CRO. (CRLS Earnings, B14) Chrysalis International Corp....
BioCentury | Jan 19, 1998
Company News

Chrysalis International, Pfizer deal

...on Pfizer's genomics data. CRLS will receive funding from Pfizer over an initial two-year period. Chrysalis International Corp....
BioCentury | Aug 11, 1997
Company News

Chrysalis International board of directors update

Chrysalis International Corp. (CRLS), Raritan, N.J. Business: Enabling technology, Supply/Service Appointed: Barry Sherman, M.D., president and CEO of Anergen Inc. WIR Staff...
BioCentury | Mar 17, 1997
Company News

Chrysalis International management update

Chrysalis International Corp. (CRLS), Raritan, N.J. Business: Enabling technology, Supply/Service Hired: Sheldon Brookman, Ph.D., as VP and general manager of the North American clinical business; formerly VP of clinical operations at PPD-Pharmaco WIR Staff...
BioCentury | Feb 18, 1997
Company News

Chrysalis International, Taconic Corp. deal

...tissues and fluids and transgenic breeding services, will sell produce, market and distribute the animals. Chrysalis International Corp....
BioCentury | Dec 23, 1996
Company News

Chrysalis International, DNX Corp., BioClin Group deal

...research organization (see BioCentury Aug. 26). Subsequently, DNXX changed its name and stock symbol to Chrysalis International...
...company was $31.1 million, and the pro forma net income was $310,000 ($0.03 per share). Chrysalis International Corp....
Items per page:
1 - 9 of 9
BioCentury | Nov 23, 1998
Company News

Chrysalis International, Phoenix International Life Sciences Inc. deal

...assume CRLS's $10.5 million debt. CRLS will downsize and consolidate certain clinical operations into PHX. Chrysalis International Corp....
BioCentury | Jul 6, 1998
Company News

Serologicals board of directors update

...Corp. (SERO), Atlanta, Ga. Business: Supply/Service Appointed: Desmond O'Connell, director and executive committee member of Chrysalis International Corp. WIR...
BioCentury | Apr 27, 1998
Company News

Chrysalis International deal

...the partner requested changes in the clinical protocol based on results from other clinical studies. Chrysalis International Corp....
BioCentury | Mar 23, 1998
Company News

Chrysalis International, MDS deal

...between CRLS and MDS’s MDS Pharmaceutical Services Division (Princeton, N.J.), a CRO. (CRLS Earnings, B14) Chrysalis International Corp....
BioCentury | Jan 19, 1998
Company News

Chrysalis International, Pfizer deal

...on Pfizer's genomics data. CRLS will receive funding from Pfizer over an initial two-year period. Chrysalis International Corp....
BioCentury | Aug 11, 1997
Company News

Chrysalis International board of directors update

Chrysalis International Corp. (CRLS), Raritan, N.J. Business: Enabling technology, Supply/Service Appointed: Barry Sherman, M.D., president and CEO of Anergen Inc. WIR Staff...
BioCentury | Mar 17, 1997
Company News

Chrysalis International management update

Chrysalis International Corp. (CRLS), Raritan, N.J. Business: Enabling technology, Supply/Service Hired: Sheldon Brookman, Ph.D., as VP and general manager of the North American clinical business; formerly VP of clinical operations at PPD-Pharmaco WIR Staff...
BioCentury | Feb 18, 1997
Company News

Chrysalis International, Taconic Corp. deal

...tissues and fluids and transgenic breeding services, will sell produce, market and distribute the animals. Chrysalis International Corp....
BioCentury | Dec 23, 1996
Company News

Chrysalis International, DNX Corp., BioClin Group deal

...research organization (see BioCentury Aug. 26). Subsequently, DNXX changed its name and stock symbol to Chrysalis International...
...company was $31.1 million, and the pro forma net income was $310,000 ($0.03 per share). Chrysalis International Corp....
Items per page:
1 - 9 of 9